BeStock  
Markets › Compare › BCAX vs DSGN

BCAX vs DSGN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BCAX · Bicara Therapeutics$8.44 ▼ 7.46%
DSGN · Design Therapeutics$9.02 ▼ 3.22%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3373113153193Nov 24, '25May 26, '26Nov 20, '26
  • BCAX -55.3%
  • DSGN +4.4%

Head to head

MetricBCAXDSGN
Price$8.44$9.02
Change today▼ 7.46%▼ 3.22%
Market cap$560.31M$577.61M
Return, 3 months-64.2%-40.8%
Return, year to date-49.9%-3.8%
Return, 1 year-53.2%+8.0%
P/E (TTM)––
P/B1.42.9
P/E percentile vs own 5y98th35th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-96.1%-19.4%
Gross margin––
Operating margin––
Net margin––
Return on equity-54.2%-36.9%
Analyst target vs. price+274.8%+140.2%
Analyst buy share88%100%
RSI (14)2833
30-day volatility189.3%68.5%
Max drawdown, 1 year-73.9%-43.4%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DSGN is the largest of the group by market value.
  • DSGN has returned the most over the past year.
  • DSGN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top